TODAY今日发布ESCHeartFailureEarlyRecent,May12,今日发布01篇HerzEarlyRecent,May12,今日发布01篇Cardiovasc?Drugs?TherEarlyRecent,May12,今日发布01篇JAMAEarlyRecent,May12,今日发布03篇JThromb?ThrombolysisEarlyRecent,May12,今日发布01篇JAMACardiologyEarlyRecent,May12,今日发布06篇NEJMMay13,:(19)今日发布19篇RECOMMEND推荐阅读01抗凝血酶III和依诺肝素剂量调整对静脉血栓栓塞高危创伤患者预防性抗Xa浓度的影响:一项随机试验JThromb?ThrombolysisArticleMollyElizabethDroege,ChristopherAllenDroege,etc.昨天23:46TheimpactofantithrombinIIIactivity(AT-III)onprophylacticenoxaparinanti-factorXaconcentration(anti-Xa)isunknowninhigh-risktraumapatients.Sotooistheoptimalanti-Xa-adjustedenoxaparindosage.Thisprospective,randomized,pilotstudysoughttoexploretheassociationbetweenAT-IIIandanti-Xagoalattainmentandtopreliminarilyevaluatetwoenoxaparindosageadjustmentstrategiesinpatientswithsubprophylacticanti-Xa.AdulttraumapatientswithRiskAssessmentProfile(RAP)?≥?5prescribedenoxaparin30?mgsubcutaneouslyevery12?hwereeligible.AT-IIIandanti-Xaweredrawn8?hafterthethirdenoxaparindoseand
转载请注明地址:http://www.bfmcc.com/zcmbjc/16743728.html
转载请注明地址:http://www.bfmcc.com/zcmbjc/16743728.html